Companies: 10,795·Total market cap: $144.5T
Zoetis Inc.

Zoetis Inc.

ZTSNYSEHealthcare● Active
$78.81
$-0.63(-0.79%)
Market Cap$33.0B
P/E Ratio
52W High$171.52
52W Low$72.38
Overview

Zoetis Inc. (ZTS) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

ZTS · free cash flow · updated Jun 8, 2026

Core FCF metrics

Free cash flow was $2.28B for FY2025 (fiscal year ending 2025-12-31), down 0.7% year-over-year The FCF margin was 24.1%. Five-year CAGR stands at +6.4%.

FY2025 Free Cash Flow$2.28B▼ -0.7% YoY
Trailing 12M (TTM)$2.14Btrailing 4 quarters sum
FCF Margin24.1%$2.28B ÷ revenue
3-Year CAGR+19.9%FY2022 → FY2025
5-Year CAGR+6.4%FY2020 → FY2025
FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

Positive FCFNegative FCF
Free Cash Flow
YoY Growth %
zts free cash flow history · zts free cash flow chart · zts free cash flow growth rate · zts free cash flow last 10 years

Annual free cash flow data

Fiscal YearFree Cash FlowYoY ChangeFCF Margin
FY2025Latest$2.28B▼ 0.7%24.1%
FY2024$2.30B▲ +41.8%24.8%
FY2023$1.62B▲ +22.2%19.0%
FY2022$1.33B▼ 23.6%16.4%
FY2021$1.74B▲ +3.8%22.3%
FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP
zts free cash flow 2025 · zts free cash flow 2024 · zts free cash flow 2023 · zts operating cash flow

FCF valuation metrics

Zoetis Inc. (ZTS) trades at a FCF yield of 6.51% and a price-to-free-cash-flow ratio of 16.4x. FCF per share stands at $4.82, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)
6.51%
Free Cash Flow ÷ Market Cap
per FMP freeCashFlowYieldTTM definition
FCF per Share (TTM)
$4.82
TTM FCF ÷ Shares Outstanding
Price / FCF
x16.4
Share Price ÷ FCF per Share
EV / FCF (TTM)
x18.8
Enterprise Value basis
Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31
zts price to free cash flow · zts free cash flow yield · zts free cash flow per share · zts price to cash flow ratio

Cash flow statement summary

For FY2025, Zoetis Inc. generated $2.90B in operating cash flow and spent 621M in capital expenditures, yielding $2.28B in free cash flow.

Operating Activities
+$2.90B
Cash from core business operations
2025-12-31
Investing Activities
−$748.0M
CapEx, acquisitions & investments
2025-12-31
Financing Activities
−$1.87B
Buybacks, dividends & debt
2025-12-31
FCF FormulaOperating CF ($2.90B) − |CapEx| (621M) = FCF ($2.28B)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement
zts cash flow statement · zts cash flow statement 2025 · zts operating cash flow · zts cash flow from operations

Free cash flow vs peers (Healthcare)

#CompanyFree Cash FlowYoY
#1
Zoetis Inc.
Zoetis Inc.YOU
ZTS
$2.28B-0.7%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$19.70B-0.7%
#3
AbbVie Inc.
AbbVie Inc.
ABBV
$17.82B-0.1%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$16.07B-22.4%
#5
Eli Lilly and Company
Eli Lilly and Company
LLY
$8.97B+2065.6%
Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Zoetis Inc. (ZTS) reported free cash flow of $2.28B for FY2025 (fiscal year ending 2025-12-31), down 0.7% year-over-year. The FCF margin was 24.1%.

Based on available data, Zoetis Inc. has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $2.30B in FY2024. The 5-year CAGR stands at +6.4%.

Zoetis Inc.'s FCF yield is 6.51% and price-to-FCF ratio is 16.4x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Frequently asked questions

ZTS free cash flow · 8 questions

Zoetis Inc. free cash flow was $2.28B for FY2025, down 0.7% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $2.14B.

ZTS free cash flowZTS FCFZTS FCF 2025ZTS free cash flow TTM

Source: FMP /cash-flow-statement · US GAAP · Zoetis Inc. · Zoetis Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026